The performance of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the patent expiration in key territories has introduced significant uncertainty . Investors are now assessing the consequences of l